StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Lipitor (atorvastatin by Quarter

Lipitor (atorvastatin — Upjohn spin-off Nov 2020) [legacy] ($M) ($M)

Pfizer Lipitor (atorvastatin: $356M in Q3 2020, down 25.2% from a year earlier. That is the lowest of the 11 quarters on record here. No newer figure appears in the documents we track.

Latest, Q3 2020
356
Period ended Sep 27, 2020
Change on a year earlier
-25.2%
476 in Q3 2019
History
11 quarters
Since Q1 2018
Sources
7
Documents cited below

Where the Q3 2020 figure comes from

Source: Form 10-Q (filed 2020-11-05) ↗

Reported in Form 10-K Segment Note.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLipitor (atorvastatin — Upjohn spin-off Nov 2020) [legacy] ($M) ($M)Year on yearSource
Q3 2020Sep 27, 2020356-25.2%Form 10-Q (filed 2020-11-05) ↗
Q2 2020Jun 28, 2020431+5.9%Form 10-Q (filed 2020-08-06) ↗
Q1 2020Mar 29, 2020405-34.9%Form 10-Q (filed 2020-05-07) ↗
Q4 2019Dec 31, 2019467-10.7%Form 10-K (filed 2020-02-27) ↗
Q3 2019Sep 29, 2019476-6.1%Form 10-Q (filed 2020-11-05) ↗
Q2 2019Jun 30, 2019407-21.9%Form 10-Q (filed 2020-08-06) ↗
Q1 2019Mar 31, 2019622+21.7%Form 10-Q (filed 2020-05-07) ↗
Q4 2018Dec 31, 2018523–Form 10-K (filed 2020-02-27) ↗
Q3 2018Sep 30, 2018507–Form 10-Q (filed 2019-11-07) ↗
Q2 2018Jul 1, 2018521–Form 10-Q (filed 2019-08-08) ↗
Q1 2018Apr 1, 2018511–Form 10-Q (filed 2019-05-09) ↗

Cite this data

StockData. (2026). Pfizer Lipitor (atorvastatin ($M), quarterly Q1 2018–Q3 2020 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/lipitor-leg

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.